|
Ceritinib plus nivolumab (NIVO) in patients (pts) with anaplastic lymphoma kinase positive (ALK+) advanced non-small cell lung cancer (NSCLC). |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Lilly; Merck Serono; MSD; Novartis; SERVIER; Tiziana Life Sciences |
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Lilly; Menarini; Roche |
|
|
Consulting or Advisory Role - Novartis |
|
|
Consulting or Advisory Role - GlaxoSmithKline; Novartis; Roche/Genentech |
Speakers' Bureau - Abbvie; Ignyta; Novartis |
Research Funding - MSD Oncology (Inst) |
Travel, Accommodations, Expenses - Bayer; MSD Oncology; Pfizer; Roche |
|
|
Honoraria - Foundation medicine; Novartis; Pfizer; Roche/Genentech |
Consulting or Advisory Role - ARIAD; Blueprint Medicines; Daiichi Sankyo; EMD Serono; Genentech; Ignyta; KSQ Therapeutics; Novartis; Pfizer; Roche; Taiho Pharmaceutical |
Research Funding - Novartis; Pfizer; Roche/Genentech |
|
|
|
Consulting or Advisory Role - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Lilly (Inst); Novartis (Inst) |
Research Funding - AstraZeneca (Inst) |
|
|
Honoraria - AstraZeneca/MedImmune; Bristol-Myers Squibb; Lilly; Pfizer; Roche |
Consulting or Advisory Role - AstraZeneca; AstraZeneca/MedImmune; Pfizer; Roche/Genentech |
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Roche |
|
|
Honoraria - novartis; pfizer |
Consulting or Advisory Role - AstraZeneca/MedImmune; novartis; pfizer; Roche Canada; takeda |
Research Funding - roche (Inst) |
|
|
Consulting or Advisory Role - Amgen (Inst); ERYTECH Pharma (Inst); Johnson & Johnson (Inst) |
Research Funding - Astellas Oncology (Inst); Johnson & Johnson (Inst); Sanofi (Inst) |
|
|
|
Stock and Other Ownership Interests - Novartis |
Travel, Accommodations, Expenses - Novartis |
|
|
|
Stock and Other Ownership Interests - Novartis |
|
|
Employment - Bristol-Myers Squibb |
Stock and Other Ownership Interests - Bristol-Myers Squibb |
|
|
|
Stock and Other Ownership Interests - Novartis |
|
|
|
Stock and Other Ownership Interests - Novartis |
|
|
Consulting or Advisory Role - Celgene; Loxo; Merck; Novartis |
Research Funding - GlaxoSmithKline (Inst); Novartis |
Travel, Accommodations, Expenses - Pfizer |